ArticleFrontiers in immunology2022

Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.

Jessy John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.